— Know what they know.
Not Investment Advice

CYTK NASDAQ

Cytokinetics, Incorporated
1W: -0.7% 1M: +17.8% 3M: +14.9% YTD: +26.4% 1Y: +139.0% 3Y: +109.7% 5Y: +201.0%
$76.94
-1.12 (-1.43%)
 
Weekly Expected Move ±10.8%
$60 $68 $76 $84 $92
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Buy · Power 67 · $9.6B mcap · 120M float · 2.09% daily turnover · Short 54% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
43.9 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 196.3%
Cost Advantage
34
Intangibles
55
Switching Cost
46
Network Effect
52
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CYTK shows a Weak competitive edge (43.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. ROIC of 196.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$103
Low
$115
Avg Target
$140
High
Based on 5 analysts since May 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 33Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$103.00
Analysts8
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-11 H.C. Wainwright $136 $140 +4 +82.0% $76.91
2026-05-06 Morgan Stanley $90 $103 +13 +39.5% $73.82
2026-05-06 UBS $69 $119 +50 +60.1% $74.34
2026-05-06 Stifel Nicolaus $96 $108 +12 +40.1% $77.09
2026-05-05 Truist Financial Srikripa Devarakonda $92 $106 +14 +38.4% $76.59
2026-04-10 Wells Fargo Initiated $95 +46.9% $64.66
2026-03-10 Robert W. Baird Roanna Ruiz Initiated $84 +32.2% $63.55
2026-03-06 UBS Ashwani Verma $61 $69 +8 +13.9% $60.59
2026-02-20 RBC Capital $95 $101 +6 +48.2% $68.13
2026-02-03 Truist Financial Srikripa Devarakonda $84 $92 +8 +38.4% $66.47
2026-01-09 Jefferies Akash Tewari $85 $90 +5 +42.3% $63.24
2026-01-08 Morgan Stanley Maxwell Skor $71 $90 +19 +37.9% $65.25
2025-12-22 Truist Financial Srikripa Devarakonda $60 $84 +24 +24.8% $67.33
2025-12-22 Morgan Stanley $67 $71 +4 +5.4% $67.39
2025-12-22 Leerink Partners Roanna Ruiz Initiated $83 +21.2% $68.45
2025-12-22 RBC Capital Initiated $95 +51.5% $62.72
2025-12-22 Needham Serge Belanger $72 $84 +12 +21.3% $69.25
2025-12-22 Goldman Sachs $95 $99 +4 +57.8% $62.72
2025-12-22 H.C. Wainwright Joseph Pantginis $120 $136 +16 +116.8% $62.72
2025-12-22 Barclays $82 $87 +5 +38.7% $62.72
2025-12-18 Goldman Sachs $60 $95 +35 +58.8% $59.82
2025-12-01 UBS Ashwani Verma Initiated $61 -9.3% $67.23
2025-10-06 Barclays Gena Wang $71 $82 +11 +43.9% $56.97
2025-09-03 Evercore ISI Cory Kasimov Initiated $80 +60.0% $49.99
2025-09-03 Barclays Gena Wang $55 $71 +16 +42.0% $49.99
2025-09-02 Stifel Nicolaus James Condulis Initiated $96 +93.5% $49.62
2025-04-24 Barclays Gena Wang $95 $55 -40 +36.4% $40.33
2025-03-06 Morgan Stanley $45 $67 +22 +54.8% $43.27
2024-10-17 H.C. Wainwright Joseph Pantginis $90 $120 +30 +117.1% $55.28
2024-09-03 Goldman Sachs Paul Choi Initiated $60 +10.0% $54.56
2024-06-10 Piper Sandler Yasmeen Rahimi $72 $107 +35 +101.1% $53.21
2024-06-04 B.Riley Financial Mayank Mamtani Initiated $92 +88.9% $48.70
2024-05-28 JMP Securities Jason Butler $106 $78 -28 +61.5% $48.30
2024-05-23 H.C. Wainwright Joseph Pantginis $75 $90 +15 +84.8% $48.71
2024-05-23 Needham Serge Belanger $58 $72 +14 +21.6% $59.23
2024-05-23 Jefferies Akash Tewari Initiated $85 +43.5% $59.23
2024-05-23 Barclays Carter Gould $52 $95 +43 +60.4% $59.23
2024-05-09 Oppenheimer Justin Kim Initiated $106 +62.4% $65.27
2024-05-09 JMP Securities Jason Butler Initiated $106 +62.4% $65.27
2024-04-05 Mizuho Securities Salim Syed Initiated $99 +36.1% $72.74
2022-12-23 Needham Initiated $58 +27.2% $45.59
2022-12-20 Truist Financial Initiated $60 +32.7% $45.22
2022-08-23 Raymond James Dane Leone $54 $63 +9 +20.8% $52.17
2022-06-09 Piper Sandler Yasmeen Rahimi Initiated $72 +85.4% $38.84
2022-04-30 H.C. Wainwright Joseph Pantginis Initiated $75 +88.1% $39.87
2021-12-19 Barclays Carter Gould Initiated $52 +31.6% $39.50
2021-11-17 Raymond James Dane Leone Initiated $54 +32.6% $40.73
2021-10-07 Morgan Stanley Jeffrey Hung Initiated $45 +18.4% $38.01

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CYTK receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

22 Grade D
Profitability
20
Balance Sheet
35
Earnings Quality
42
Growth
52
Value
32
Momentum
50
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CYTK scores highest in Growth (52/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-2.16
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
-31.72
Unlikely Manipulator
Ohlson O-Score
-1.29
Bankruptcy prob: 21.5%
Moderate
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
OCF/NI: 0.63x
Accruals: -21.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CYTK scores -2.16, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CYTK scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CYTK's score of -31.72 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CYTK's implied 21.5% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CYTK receives an estimated rating of B- (score: 20.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-11.43x
PEG
0.42x
P/S
90.48x
P/B
-11.47x
P/FCF
-14.80x
P/OCF
EV/EBITDA
-11.44x
EV/Revenue
80.58x
EV/EBIT
-11.27x
EV/FCF
-15.53x
Earnings Yield
-10.21%
FCF Yield
-6.76%
Shareholder Yield
0.26%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CYTK currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.096
EBT / EBIT
×
EBIT Margin
-7.150
EBIT / Rev
×
Asset Turnover
0.075
Rev / Assets
×
Equity Multiplier
-3.555
Assets / Equity
=
ROE
208.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CYTK's ROE of 208.7% is driven by Asset Turnover (0.075), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$76.94
Median 1Y
$83.70
5th Pctile
$28.15
95th Pctile
$247.40
Ann. Volatility
68.2%
Analyst Target
$103.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Robert I. Blum,
Principal Executive Officer
$853,069 $5,150,019 $11,881,456
Jeffrey Hessekiel, President,
Vice President, Chief Legal & Administrative Officer
$85,250 $5,800,013 $6,086,217
Fady I. Malik,
Executive Vice President, Research and Development
$629,781 $1,750,002 $4,467,066
Andrew M. Callos,
Executive Vice President, Chief Commercial Officer
$581,678 $1,449,995 $3,787,644
Sung H. Lee,
Principal Financial Officer
$572,918 $1,449,995 $3,770,807

CEO Pay Ratio

5:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $2,177,957
Avg Employee Cost (SGA/emp): $422,394
Employees: 673

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
673
+35.1% YoY
Revenue / Employee
$130,816
Rev: $88,039,000
Profit / Employee
$-1,166,352
NI: $-784,955,000
SGA / Employee
$422,394
Avg labor cost proxy
R&D / Employee
$603,122
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -3.0% -4.5% -1.2% -1.4% -1.2% -1.6% -5.7% -6.3% -7.9% -7.7% 2.1% 2.1% 2.2% 2.3% 2.3% 2.4% 2.3% 2.9% 2.0% 2.1% 2.09%
ROA -37.8% -55.5% -31.3% -37.5% -31.4% -41.0% -41.9% -46.4% -58.1% -56.8% -57.2% -57.7% -59.3% -62.7% -53.0% -55.3% -54.5% -67.6% -55.5% -58.7% -58.71%
ROIC 47.2% 75.0% -3.5% -4.2% -3.4% -4.1% 1.8% 2.1% 2.7% 2.8% 1.6% 1.6% 1.6% 1.7% 1.0% 1.1% 1.0% 1.1% 1.9% 2.0% 1.96%
ROCE -24.7% -39.4% -24.2% -29.3% -23.5% -31.0% -36.3% -40.4% -51.7% -50.5% -64.9% -65.0% -65.5% -68.7% -41.2% -42.8% -42.1% -53.7% -58.2% -61.9% -61.91%
Gross Margin -11.8% -7.9% 21.8% -39.0% 35.8% -23.9% -37.3% -16.2% -95.0% -217.3% -49.8% -96.7% -318.7% -181.7% -4.5% -62.2% 96.6% -38.4% 83.9% 87.6% 87.64%
Operating Margin -19.3% -12.7% -39.0% -67.8% -12.2% -43.1% -64.9% -27.0% -140.8% -323.5% -76.2% -151.2% -522.8% -304.1% -8.2% -98.6% -1.7% -86.1% -10.0% -9.5% -9.49%
Net Margin -21.7% -14.0% -55.0% -77.9% -22.3% -56.6% -70.2% -28.5% -148.4% -342.4% -81.9% -162.4% -575.6% -346.7% -8.9% -102.2% -2.0% -158.1% -10.3% -10.6% -10.64%
EBITDA Margin -19.0% -12.6% -34.9% -68.4% -9.0% -49.5% -60.5% -25.0% -129.7% -300.5% -67.9% -138.9% -468.3% -293.4% -7.4% -86.2% -1.6% -143.2% -10.2% -9.3% -9.31%
FCF Margin -29.5% -3.9% -2.7% -2.8% -1.6% -1.8% -3.3% -4.1% -43.7% -56.7% -55.2% -112.2% -127.5% -126.5% -21.6% -21.3% -5.1% -5.2% -6.1% -5.2% -5.19%
OCF Margin 13.0% -2.1% -2.0% -2.2% -1.3% -1.6% -3.1% -4.0% -42.6% -56.1% -55.0% -112.4% -127.3% -125.6% -21.4% -20.7% -5.0% -5.0% -5.8% -5.0% -4.95%
ROA 3Y Avg snapshot only -55.50%
ROIC Economic snapshot only -81.25%
Cash ROA snapshot only -36.77%
NOPAT Margin snapshot only -4.78%
Pretax Margin snapshot only -7.84%
R&D / Revenue snapshot only 3.86%
SGA / Revenue snapshot only 3.14%
SBC / Revenue snapshot only 83.75%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -9.12 -12.55 -17.80 -12.14 -15.60 -16.10 -11.15 -7.77 -5.79 -5.37 -15.72 -13.47 -10.85 -10.78 -9.42 -7.74 -6.51 -8.77 -9.91 -9.79 -11.433
P/S Ratio 24.57 133.22 54.42 48.11 22.28 30.65 45.87 34.15 313.86 362.16 1098.42 1904.56 1888.52 1930.34 300.65 247.81 46.03 75.61 88.36 76.78 90.477
P/B Ratio 12.52 25.32 15.72 12.83 13.81 18.63 -40.21 -31.04 -28.95 -26.23 -21.41 -18.50 -15.32 -16.08 -41.03 -35.18 -29.16 -48.71 -11.79 -12.32 -11.475
P/FCF -83.22 -34.46 -20.03 -17.10 -14.27 -16.85 -14.07 -8.30 -7.19 -6.39 -19.89 -16.98 -14.81 -15.27 -13.89 -11.63 -8.96 -14.54 -14.55 -14.80 -14.802
P/OCF 189.28
EV/EBITDA -8.98 -12.98 -19.98 -13.27 -18.15 -18.84 -13.07 -9.06 -6.57 -6.09 -18.50 -16.00 -13.18 -13.19 -10.67 -8.71 -7.25 -9.76 -11.66 -11.44 -11.437
EV/Revenue 18.94 118.14 51.56 45.01 20.95 29.28 45.52 33.82 310.62 358.03 1117.14 1942.12 1933.49 1974.13 285.10 232.86 42.68 72.32 92.93 80.58 80.584
EV/EBIT -8.83 -12.85 -19.52 -12.96 -17.48 -18.18 -12.75 -8.83 -6.43 -5.95 -17.95 -15.54 -12.82 -12.83 -10.47 -8.55 -7.12 -9.62 -11.50 -11.27 -11.270
EV/FCF -64.17 -30.56 -18.97 -15.99 -13.42 -16.10 -13.96 -8.22 -7.11 -6.32 -20.23 -17.32 -15.17 -15.61 -13.17 -10.93 -8.31 -13.91 -15.30 -15.53 -15.534
Earnings Yield -11.0% -8.0% -5.6% -8.2% -6.4% -6.2% -9.0% -12.9% -17.3% -18.6% -6.4% -7.4% -9.2% -9.3% -10.6% -12.9% -15.4% -11.4% -10.1% -10.2% -10.21%
FCF Yield -1.2% -2.9% -5.0% -5.8% -7.0% -5.9% -7.1% -12.0% -13.9% -15.7% -5.0% -5.9% -6.8% -6.6% -7.2% -8.6% -11.2% -6.9% -6.9% -6.8% -6.76%
PEG Ratio snapshot only 0.424
EV/Gross Profit snapshot only 89.196
Shareholder Yield snapshot only 0.26%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 15.20 15.20 7.45 7.45 7.45 7.45 9.40 9.40 9.40 9.40 6.12 6.12 6.12 6.12 6.17 6.17 6.17 6.17 4.53 4.53 4.529
Quick Ratio 15.20 15.20 7.45 7.45 7.45 7.45 9.40 9.40 9.40 9.40 6.12 6.12 6.12 6.12 6.17 6.17 6.17 6.17 4.53 4.53 4.529
Debt/Equity 1.23 1.23 1.11 1.11 1.11 1.11 -6.95 -6.95 -6.95 -6.95 -1.96 -1.96 -1.96 -1.96 -5.83 -5.83 -5.83 -5.83 -1.95 -1.95 -1.947
Net Debt/Equity -2.87 -2.87 -0.83 -0.83 -0.83 -0.83
Debt/Assets 0.26 0.26 0.32 0.32 0.32 0.32 0.74 0.74 0.74 0.74 0.92 0.92 0.92 0.92 0.56 0.56 0.56 0.56 0.90 0.90 0.902
Debt/EBITDA -1.14 -0.71 -1.49 -1.22 -1.55 -1.17 -2.28 -2.05 -1.59 -1.63 -1.66 -1.66 -1.64 -1.57 -1.60 -1.54 -1.56 -1.22 -1.83 -1.72 -1.722
Net Debt/EBITDA 2.67 1.66 1.11 0.91 1.16 0.88 0.10 0.09 0.07 0.07 -0.31 -0.31 -0.31 -0.29 0.58 0.56 0.57 0.44 -0.57 -0.54 -0.539
Interest Coverage -3.78 -6.49 -6.26 -7.00 -5.16 -5.46 -6.60 -6.82 -8.20 -8.26 -8.13 -7.59 -6.50 -6.12 -5.81 -5.68 -5.58 -6.82 -6.85 -6.62 -6.622
Equity Multiplier 4.71 4.71 3.45 3.45 3.45 3.45 -9.40 -9.40 -9.40 -9.40 -2.13 -2.13 -2.13 -2.13 -10.35 -10.35 -10.35 -10.35 -2.16 -2.16 -2.160
Cash Ratio snapshot only 4.358
Debt Service Coverage snapshot only -6.526
Cash to Debt snapshot only 0.687
FCF to Debt snapshot only -0.427
Defensive Interval snapshot only 437.6 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.14 0.05 0.10 0.09 0.22 0.22 0.10 0.11 0.01 0.01 0.01 0.00 0.00 0.00 0.02 0.02 0.08 0.08 0.06 0.07 0.075
Inventory Turnover
Receivables Turnover 12.06 4.50 2.50 2.31 5.38 5.27 3.64 3.77 0.38 0.30 10.53 5.25 4.38 4.50 2.06 2.14 9.56 9.73 10.58 12.71 12.711
Payables Turnover 14.98 17.97 10.98 11.96 13.38 14.37 10.31 11.75 12.86 13.71 14.01 14.10 13.95 14.04 16.21 17.08 13.39 9.48 1.71 0.16 0.162
DSO 30 81 146 158 68 69 100 97 953 1214 35 70 83 81 177 170 38 38 35 29 28.7 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 24 20 33 31 27 25 35 31 28 27 26 26 26 26 23 21 27 39 214 2250 2250.4 days
Cash Conversion Cycle 6 61 112 127 41 44 65 66 925 1187 9 44 57 55 155 149 11 -1 -179 -2222 -2221.7 days
Fixed Asset Turnover snapshot only 0.682
Cash Velocity snapshot only 0.120
Capital Intensity snapshot only 13.463
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 2.1% -60.3% 26.2% 11.1% 1.6% 5.9% 34.3% 50.8% -93.4% -94.7% -92.0% -96.2% -68.5% -58.8% 1.5% 4.1% 26.4% 26.1% 3.8% 4.5% 4.51%
Net Income -10.9% -1.0% -69.2% -90.9% -38.6% -23.4% -80.6% -67.2% -1.5% -86.7% -35.3% -23.2% -1.0% -9.4% -12.0% -16.0% -11.2% -30.5% -33.2% -34.8% -34.84%
EPS 7.8% -70.5% -42.5% -59.9% -16.0% -5.7% -60.4% -49.3% -1.2% -82.2% -29.3% -15.0% 11.4% 10.7% 6.0% 0.3% -1.7% -28.0% -28.4% -29.6% -29.61%
FCF 83.1% -22.4% -89.8% -24.9% -12.8% -2.2% -61.2% -1.2% -84.1% -64.4% -34.8% -4.3% 8.1% 8.1% 3.8% 2.7% -10.3% -11.4% -33.8% -34.1% -34.10%
EBITDA -16.0% -1.6% -1.1% -1.2% -43.1% -17.5% -81.2% -66.0% -1.7% -99.5% -38.1% -24.4% 2.3% -4.8% -8.5% -12.8% -9.8% -34.1% -42.1% -45.2% -45.16%
Op. Income -14.8% -1.5% -98.3% -1.1% -41.9% -8.9% -74.0% -65.9% -1.7% -1.3% -53.1% -34.3% -5.0% -5.8% -8.1% -13.6% -8.1% -9.2% -14.2% -13.2% -13.19%
OCF Growth snapshot only -31.62%
Asset Growth snapshot only 1.63%
Debt Growth snapshot only 62.84%
Shares Change snapshot only 4.03%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 48.5% -0.8% 30.8% 23.3% 61.9% 68.4% 52.1% 64.0% -18.9% -47.6% -48.7% -60.0% -62.2% -46.9% -36.0% -33.4% -17.2% -16.2% -2.4% 2.6% 2.57%
Revenue 5Y 12.6% -23.6% -7.9% -8.6% 8.7% 26.1% 47.9% 46.6% -10.8% -18.8% -24.9% -35.9% -38.5% -36.4% -7.2% -2.9% 35.6% 9.9% 9.5% 12.6% 12.56%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 21.9% 21.9% 58.5% 58.5% 58.5% 58.5% 51.9% 51.9% 51.9% 51.9% 15.6% 15.6% 15.6% 15.6% 18.5% 18.5% 18.5% 18.5% 12.0% 12.0% 11.97%
Assets 5Y 35.9% 35.9% 37.7% 37.7% 37.7% 37.7% 28.0% 28.0% 28.0% 28.0% 31.3% 31.3% 31.3% 31.3% 37.1% 37.1% 37.1% 37.1% 21.7% 21.7% 21.69%
Equity 3Y 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%
Book Value 3Y -7.9% -11.1% 82.9% 82.4% 84.9% 80.5%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.18 0.42 0.15 0.16 0.06 0.28 0.94 0.89 0.11 0.05 0.00 0.00 0.04 0.02 0.05 0.03 0.00 0.03 0.00 0.00 0.002
Earnings Stability 0.74 0.81 0.71 0.74 0.81 0.81 0.65 0.69 0.61 0.77 0.86 0.89 0.82 0.92 0.95 0.96 0.88 0.97 0.99 0.99 0.985
Margin Stability 0.26 0.00 0.10 0.13 0.00 0.00 0.13 0.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.00 1.00 1.00 1.00 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.96 0.50 0.50 0.50 0.85 0.91 0.50 0.50 0.50 0.50 0.86 0.91 1.00 0.96 0.95 0.94 0.96 0.88 0.87 0.86 0.861
Earnings Smoothness
ROE Trend
Gross Margin Trend 1.39 -4.50 0.20 0.13 1.96 2.76 -0.54 -0.55 -28.49 -36.88 -41.43 -85.82 -89.14 -81.56 4.82 27.07 64.26 69.58 29.88 53.49 53.489
FCF Margin Trend 3.77 -1.86 -0.96 -0.56 1.29 0.74 -1.88 -2.65 -42.74 -53.85 -52.22 -108.69 -104.87 -97.20 7.60 36.84 80.44 86.37 32.35 61.54 61.541
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -0.05 0.20 0.66 0.54 0.93 0.86 0.76 0.91 0.79 0.83 0.79 0.79 0.73 0.70 0.67 0.65 0.70 0.58 0.65 0.63 0.631
FCF/OCF -2.27 1.83 1.34 1.31 1.18 1.11 1.04 1.03 1.03 1.01 1.00 1.00 1.00 1.01 1.01 1.03 1.03 1.05 1.05 1.05 1.048
FCF/Net Income snapshot only 0.662
CapEx/Revenue 42.5% 1.7% 69.4% 66.4% 23.3% 17.5% 12.0% 11.0% 1.1% 58.1% 18.8% 19.7% 14.6% 83.7% 21.1% 58.9% 15.8% 23.5% 28.2% 23.7% 23.70%
CapEx/Depreciation snapshot only 2.275
Accruals Ratio -0.40 -0.44 -0.11 -0.17 -0.02 -0.06 -0.10 -0.04 -0.12 -0.10 -0.12 -0.12 -0.16 -0.19 -0.17 -0.20 -0.16 -0.29 -0.19 -0.22 -0.216
Sloan Accruals snapshot only -0.159
Cash Flow Adequacy snapshot only -20.893
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.3% 0.3% 0.26%
Net Buyback Yield -16.1% -10.6% -8.2% -10.0% -9.4% -0.3% -0.4% -0.6% -0.6% -0.8% -2.0% -3.6% -14.7% -14.1% -13.0% -13.3% -0.7% 0.2% 0.1% 0.0% 0.04%
Total Shareholder Return -16.1% -10.6% -8.2% -10.0% -9.4% -0.3% -0.4% -0.6% -0.6% -0.8% -2.0% -3.6% -14.7% -14.1% -13.0% -13.3% -0.7% 0.2% 0.1% 0.0% 0.04%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.26 1.15 1.16 1.14 1.19 1.18 1.15 1.15 1.12 1.12 1.12 1.13 1.15 1.16 1.17 1.18 1.18 1.15 1.10 1.10 1.096
EBIT Margin -2.15 -9.20 -2.64 -3.47 -1.20 -1.61 -3.57 -3.83 -48.33 -60.12 -62.23 -124.96 -150.80 -153.90 -27.23 -27.22 -6.00 -7.52 -8.08 -7.15 -7.150
Asset Turnover 0.14 0.05 0.10 0.09 0.22 0.22 0.10 0.11 0.01 0.01 0.01 0.00 0.00 0.00 0.02 0.02 0.08 0.08 0.06 0.07 0.075
Equity Multiplier 8.04 8.04 3.85 3.85 3.85 3.85 13.65 13.65 13.65 13.65 -3.72 -3.72 -3.72 -3.72 -4.27 -4.27 -4.27 -4.27 -3.55 -3.55 -3.555
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-2.17 $-2.85 $-2.56 $-3.03 $-2.52 $-3.01 $-4.11 $-4.53 $-5.64 $-5.48 $-5.31 $-5.21 $-4.99 $-4.90 $-4.99 $-5.19 $-5.08 $-6.27 $-6.41 $-6.73 $-6.73
Book Value/Share $1.58 $1.41 $2.90 $2.87 $2.84 $2.60 $-1.14 $-1.13 $-1.13 $-1.12 $-3.90 $-3.79 $-3.54 $-3.28 $-1.15 $-1.14 $-1.13 $-1.13 $-5.39 $-5.35 $-6.71
Tangible Book/Share $1.58 $1.41 $2.90 $2.87 $2.84 $2.60 $-1.14 $-1.13 $-1.13 $-1.12 $-3.90 $-3.79 $-3.54 $-3.28 $-1.15 $-1.14 $-1.13 $-1.13 $-5.39 $-5.35 $-5.35
Revenue/Share $0.81 $0.27 $0.84 $0.77 $1.76 $1.58 $1.00 $1.03 $0.10 $0.08 $0.08 $0.04 $0.03 $0.03 $0.16 $0.16 $0.72 $0.73 $0.72 $0.86 $0.86
FCF/Share $-0.24 $-1.04 $-2.28 $-2.15 $-2.75 $-2.87 $-3.26 $-4.24 $-4.54 $-4.61 $-4.20 $-4.13 $-3.66 $-3.46 $-3.39 $-3.45 $-3.69 $-3.78 $-4.37 $-4.45 $-4.45
OCF/Share $0.10 $-0.57 $-1.69 $-1.64 $-2.34 $-2.60 $-3.14 $-4.13 $-4.43 $-4.56 $-4.18 $-4.14 $-3.65 $-3.44 $-3.35 $-3.36 $-3.57 $-3.61 $-4.17 $-4.25 $-4.25
Cash/Share $6.47 $5.78 $5.61 $5.55 $5.50 $5.03 $8.27 $8.22 $8.17 $8.15 $6.21 $6.03 $5.63 $5.22 $9.11 $9.08 $9.01 $8.97 $7.21 $7.16 $6.64
EBITDA/Share $-1.70 $-2.44 $-2.16 $-2.59 $-2.04 $-2.46 $-3.48 $-3.85 $-4.91 $-4.78 $-4.59 $-4.47 $-4.21 $-4.10 $-4.18 $-4.33 $-4.23 $-5.39 $-5.73 $-6.05 $-6.05
Debt/Share $1.94 $1.73 $3.21 $3.18 $3.15 $2.88 $7.92 $7.88 $7.84 $7.81 $7.63 $7.42 $6.92 $6.42 $6.68 $6.66 $6.60 $6.57 $10.49 $10.42 $10.42
Net Debt/Share $-4.53 $-4.05 $-2.40 $-2.37 $-2.35 $-2.15 $-0.34 $-0.34 $-0.34 $-0.34 $1.42 $1.38 $1.29 $1.20 $-2.43 $-2.42 $-2.41 $-2.39 $3.28 $3.26 $3.26
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -2.164
Altman Z-Prime snapshot only -4.165
Piotroski F-Score 6 3 3 2 4 4 4 5 3 3 1 1 1 2 6 6 6 6 4 4 4
Beneish M-Score -4.51 -2.97 -3.88 55.00 6.74 19.02 -13.00 -0.26 -21.55 -6.03 5.06 38.42 22.08 2.41 11.18 3.81 60.25 251.35 -7.19 -31.72 -31.717
Ohlson O-Score snapshot only -1.294
Net-Net WC snapshot only $-9.47
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B-
Credit Score 26.90 36.47 42.17 32.89 38.07 44.76 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 15
Sector Credit Rank snapshot only 14

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms